Cargando…
Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
Tight glycemic control is important in reducing and delaying vascular complications in type 1 and 2 diabetes patients; however, the benefits achieved through strict metabolic control are counterbalanced by an increased risk of hypoglycemia. Glucagon is an effective therapy for treating severe hypogl...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180523/ https://www.ncbi.nlm.nih.gov/pubmed/21969805 http://dx.doi.org/10.2147/DMSO.S20633 |
_version_ | 1782212656001712128 |
---|---|
author | Kedia, Nitil |
author_facet | Kedia, Nitil |
author_sort | Kedia, Nitil |
collection | PubMed |
description | Tight glycemic control is important in reducing and delaying vascular complications in type 1 and 2 diabetes patients; however, the benefits achieved through strict metabolic control are counterbalanced by an increased risk of hypoglycemia. Glucagon is an effective therapy for treating severe hypoglycemia. Available as an emergency kit, glucagon is an essential tool for rapid response, but remains underappreciated and underused. This article reviews the role of glucagon in treating severe hypoglycemia and discusses the need for better education on glucagon for people with diabetes and their caregivers in order to alleviate fears of hypoglycemia and of administering glucagon in the event of an emergency. |
format | Online Article Text |
id | pubmed-3180523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-31805232011-10-03 Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach Kedia, Nitil Diabetes Metab Syndr Obes Review Tight glycemic control is important in reducing and delaying vascular complications in type 1 and 2 diabetes patients; however, the benefits achieved through strict metabolic control are counterbalanced by an increased risk of hypoglycemia. Glucagon is an effective therapy for treating severe hypoglycemia. Available as an emergency kit, glucagon is an essential tool for rapid response, but remains underappreciated and underused. This article reviews the role of glucagon in treating severe hypoglycemia and discusses the need for better education on glucagon for people with diabetes and their caregivers in order to alleviate fears of hypoglycemia and of administering glucagon in the event of an emergency. Dove Medical Press 2011-09-06 /pmc/articles/PMC3180523/ /pubmed/21969805 http://dx.doi.org/10.2147/DMSO.S20633 Text en © 2011 Kedia, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Review Kedia, Nitil Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach |
title | Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach |
title_full | Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach |
title_fullStr | Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach |
title_full_unstemmed | Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach |
title_short | Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach |
title_sort | treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180523/ https://www.ncbi.nlm.nih.gov/pubmed/21969805 http://dx.doi.org/10.2147/DMSO.S20633 |
work_keys_str_mv | AT kedianitil treatmentofseverediabetichypoglycemiawithglucagonanunderutilizedtherapeuticapproach |